July 9, 2013

MLSC joins Boston Biomedical for the grand opening of its Cambridge headquarters

From left to right: Masayo Tada-san, President and CEO of Dainippon Sumitomo Pharma (DSP) and Chairman of Boston Biomedical, Inc. (BBI), joins Dr. Chiang Li, President and CEO of BBI at the ribbon-cutting ceremony celebrating the opening of BBI’s new office in Cambridge, Mass.
From left to right: Masayo Tada-san, President and CEO of Dainippon Sumitomo Pharma (DSP) and Chairman of Boston Biomedical, Inc. (BBI), joins Dr. Chiang Li, President and CEO of BBI at the ribbon-cutting ceremony celebrating the opening of BBI’s new office in Cambridge, Mass.

Boston Biomedical, Inc., on July 9, 2013, celebrated the relocation of its headquarters to Cambridge, Massachusetts with a grand opening ceremony. Academic, business and government leaders, as well as executives from Dainippon Sumitomo Pharma Co., Ltd. (DSP), the parent company of BBI, joined the celebration.